132 related articles for article (PubMed ID: 8529284)
1. Repair analysis of 4-hydroperoxycyclophosphamide-induced DNA interstrand crosslinking in the c-myc gene in 4-hydroperoxycyclophosphamide-sensitive and -resistant medulloblastoma cell lines.
Dong Q; Bullock N; Ali-Osman F; Colvin OM; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1996; 37(3):242-46. PubMed ID: 8529284
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide resistance in medulloblastoma.
Friedman HS; Colvin OM; Kaufmann SH; Ludeman SM; Bullock N; Bigner DD; Griffith OW
Cancer Res; 1992 Oct; 52(19):5373-8. PubMed ID: 1356617
[TBL] [Abstract][Full Text] [Related]
3. The gene expression profiles of medulloblastoma cell lines resistant to preactivated cyclophosphamide.
Bacolod MD; Lin SM; Johnson SP; Bullock NS; Colvin M; Bigner DD; Friedman HS
Curr Cancer Drug Targets; 2008 May; 8(3):172-9. PubMed ID: 18473730
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cyclophosphamide activity by O6-alkylguanine-DNA alkyltransferase.
Friedman HS; Pegg AE; Johnson SP; Loktionova NA; Dolan ME; Modrich P; Moschel RC; Struck R; Brent TP; Ludeman S; Bullock N; Kilborn C; Keir S; Dong Q; Bigner DD; Colvin OM
Cancer Chemother Pharmacol; 1999; 43(1):80-5. PubMed ID: 9923545
[TBL] [Abstract][Full Text] [Related]
5. Multiple DNA repair mechanisms and alkylator resistance in the human medulloblastoma cell line D-283 Med (4-HCR).
Dong Q; Johnson SP; Colvin OM; Bullock N; Kilborn C; Runyon G; Sullivan DM; Easton J; Bigner DD; Nahta R; Marks J; Modrich P; Friedman HS
Cancer Chemother Pharmacol; 1999; 43(1):73-9. PubMed ID: 9923544
[TBL] [Abstract][Full Text] [Related]
6. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells.
Hilton J
Biochem Pharmacol; 1984 Jun; 33(12):1867-72. PubMed ID: 6732847
[TBL] [Abstract][Full Text] [Related]
7. Busulfan therapy of central nervous system xenografts in athymic mice.
Aaron RH; Elion GB; Colvin OM; Graham M; Keir S; Bigner DD; Friedman HS
Cancer Chemother Pharmacol; 1994; 35(2):127-31. PubMed ID: 7987988
[TBL] [Abstract][Full Text] [Related]
8. Depletion of cellular glutathione by N,N'-bis(trans-4-hydroxycyclohexyl)-N'-nitrosourea as a determinant of sensitivity of K562 human leukemia cells to 4-hydroperoxycyclophosphamide.
Chresta CM; Crook TR; Souhami RL
Cancer Res; 1990 Jul; 50(13):4067-71. PubMed ID: 2354456
[TBL] [Abstract][Full Text] [Related]
9. Decrease of Nibrin expression in chronic hypoxia is associated with hypoxia-induced chemoresistance in some brain tumour cells.
Cowman S; Fan YN; Pizer B; Sée V
BMC Cancer; 2019 Apr; 19(1):300. PubMed ID: 30943920
[TBL] [Abstract][Full Text] [Related]
10. Expression of the c-Myc protein in childhood medulloblastoma.
Bruggers CS; Tai KF; Murdock T; Sivak L; Le K; Perkins SL; Coffin CM; Carroll WL
J Pediatr Hematol Oncol; 1998; 20(1):18-25. PubMed ID: 9482408
[TBL] [Abstract][Full Text] [Related]
11. Cellular mechanisms of cyclophosphamide resistance: model studies in human medulloblastoma cell lines.
Friedman HS; Johnson SP; Colvin OM
Cancer Treat Res; 2002; 112():199-209. PubMed ID: 12481718
[No Abstract] [Full Text] [Related]
12. Effect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclo-phosphamide-induced programmed cell death or apoptosis in human myeloid leukemia cells.
Bullock G; Tang C; Tourkina E; Ibrado AM; Lutzky J; Huang Y; Mahoney ME; Bhalla K
Exp Hematol; 1993 Dec; 21(13):1640-7. PubMed ID: 8243566
[TBL] [Abstract][Full Text] [Related]
13. Oxidative DNA damage induced by a hydroperoxide derivative of cyclophosphamide.
Murata M; Suzuki T; Midorikawa K; Oikawa S; Kawanishi S
Free Radic Biol Med; 2004 Sep; 37(6):793-802. PubMed ID: 15304255
[TBL] [Abstract][Full Text] [Related]
14. In vitro selection for K562 cells with higher retrovirally mediated copy number of aldehyde dehydrogenase class-1 and higher resistance to 4-hydroperoxycyclophosphamide.
Moreb JS; Schweder M; Gray B; Zucali J; Zori R
Hum Gene Ther; 1998 Mar; 9(5):611-9. PubMed ID: 9551609
[TBL] [Abstract][Full Text] [Related]
15. c-Myc promoter activation in medulloblastoma.
Siu IM; Lal A; Blankenship JR; Aldosari N; Riggins GJ
Cancer Res; 2003 Aug; 63(16):4773-6. PubMed ID: 12941792
[TBL] [Abstract][Full Text] [Related]
16. Gene-specific DNA interstrand cross-links produced by nitrogen mustard in the human tumor cell line Colo320HSR.
Futscher BW; Pieper RO; Dalton WS; Erickson LC
Cell Growth Differ; 1992 Apr; 3(4):217-23. PubMed ID: 1515367
[TBL] [Abstract][Full Text] [Related]
17. DNA repair initiated in chronic lymphocytic leukemia lymphocytes by 4-hydroperoxycyclophosphamide is inhibited by fludarabine and clofarabine.
Yamauchi T; Nowak BJ; Keating MJ; Plunkett W
Clin Cancer Res; 2001 Nov; 7(11):3580-9. PubMed ID: 11705880
[TBL] [Abstract][Full Text] [Related]
18. Expression of antisense RNA to aldehyde dehydrogenase class-1 sensitizes tumor cells to 4-hydroperoxycyclophosphamide in vitro.
Moreb JS; Maccow C; Schweder M; Hecomovich J
J Pharmacol Exp Ther; 2000 May; 293(2):390-6. PubMed ID: 10773007
[TBL] [Abstract][Full Text] [Related]
19. Calbindin-D28k in subsets of medulloblastomas and in the human medulloblastoma cell line D283 Med.
Katsetos CD; Herman MM; Krishna L; Vender JR; Vinores SA; Agamanolis DP; Schiffer D; Burger PC; Urich H
Arch Pathol Lab Med; 1995 Aug; 119(8):734-43. PubMed ID: 7646332
[TBL] [Abstract][Full Text] [Related]
20. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
